{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Oklahoma City",
      "state": "OK",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "95922",
      "recalling_firm": "PD-Rx Pharmaceuticals, Inc.",
      "address_1": "727 N Ann Arbor Ave",
      "address_2": "",
      "postal_code": "73127-5822",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "Distributed within US: FL, MS, WI",
      "recall_number": "D-0163-2025",
      "product_description": "DULoxetine DR USP, 30 mg, 90-count bottle, Rx Only, Packaged by: PD Rx Pharmaceuticals Inc, Oklahoma City, OK 73127, NDC: 43063-877-90",
      "product_quantity": "70, 90-count bottles",
      "reason_for_recall": "CGMP Deviations: the presence of a Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Duloxetine above the interim acceptable intake limit",
      "recall_initiation_date": "20241204",
      "center_classification_date": "20241223",
      "termination_date": "20250321",
      "report_date": "20250101",
      "code_info": "Lot # I24E77, A24E49, Exp Date: 04/30/25;  J23C50, J23C97, L23B39, L23E98, Exp Date: 01/31/2025",
      "more_code_info": ""
    }
  ]
}